XML 53 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation And Employee Benefit Plans (Tables)
12 Months Ended
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Assumptions Used In The Black-Scholes Valuation Model
 
 
Stock Option Grants
 
ESPP Purchase Rights
 
 
Year Ended March 31,
 
Year Ended March 31,
 
 
2015
 
2017
 
2016
 
2015
Risk-free interest rate
 
1.1 - 1.9%

 
0.5 - 0.8%

 
0.3 - 0.6%

 
0.04 - 0.2%

Expected volatility
 
36 - 40%

 
25 - 32%

 
32 - 36%

 
30 - 35%

Weighted-average volatility
 
38
%
 
27
%
 
33
%
 
34
%
Expected term
 
4.5 years

 
6 - 12 months

 
6 - 12 months

 
6 - 12 months

Expected dividends
 
None

 
None

 
None

 
None

Schedule Of Assumptions Used In Monte-Carlo Simulation Model
The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows: 
 
Year Ended March 31,
 
2017
 
2016
 
2015
Risk-free interest rate
0.8
%
 
1.0
%
 
0.9
%
Expected volatility
16 - 57%

 
14 - 53%

 
16 - 79%

Weighted-average volatility
29
%
 
26
%
 
30
%
Expected dividends
None

 
None

 
None

Schedule Of Stock-Based Compensation Expense By Statement Of Operations
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, and the ESPP purchase rights included in our Consolidated Statements of Operations (in millions):
 
 
Year Ended March 31,
 
 
2017
 
2016
 
2015
Cost of revenue
 
$
3

 
$
2

 
$
2

Research and development
 
109

 
103

 
82

Marketing and sales
 
31

 
24

 
21

General and administrative
 
53

 
49

 
39

Stock-based compensation expense
 
$
196

 
$
178

 
$
144

Summary Of Outstanding And Exercisable Stock Options
The following table summarizes outstanding and exercisable stock options as of March 31, 2017: 
 
 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
 
Number
of Shares
(in thousands)
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Weighted-
Average
Exercise
Prices
 
Potential
Dilution
 
Number
of Shares
(in thousands)
 
Weighted-
Average
Exercise
Prices
 
Potential
Dilution
$11.53 - $23.61
 
178

 
2.48
 
$
19.40

 
0.1
%
 
178

 
$
19.40

 
0.1
%
26.25 - 26.25
 
950

 
6.58
 
26.25

 
0.3
%
 
770

 
26.25

 
0.2
%
33.60 - 35.70
 
597

 
7.22
 
35.45

 
0.2
%
 
372

 
35.30

 
0.1
%
36.00 - 58.14
 
652

 
2.44
 
45.59

 
0.2
%
 
583

 
46.59

 
0.2
%
$11.53 - $58.14
 
2,377

 
5.30
 
$
33.35

 
0.8
%
 
1,903

 
$
33.61

 
0.6
%
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]
The following table summarizes our ESPP activity for fiscal years ended March 31, 2017, 2016 and 2015: 
 
 
Shares Issued
(in millions)
 
Exercise Prices for Purchase Rights
 
Weighted-Average Fair Values of Purchase Rights
Fiscal Year 2015
 
1.4

 
$22.64 - $32.16
 
$
8.26

Fiscal Year 2016
 
0.9

 
$32.16 - $54.78
 
$
12.97

Fiscal Year 2017
 
0.7

 
$54.60 - $67.56
 
$
17.93

Shares Repurchased and Retired

The following table summarizes total shares repurchased during fiscal years 2017, 2016, and 2015:
 
May 2014 Program
 
May 2015 Program
 
February 2016 Program
 
Total
(In millions)
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
 
Shares
 
Amount
Fiscal Year 2015
8.2

 
$
337

 

 
$

 

 
$

 
8.2

 
$
337

Fiscal Year 2016
1.0

 
$
57

 
6.9

 
$
461

 
7.8

 
$
500

 
15.7

 
$
1,018

Fiscal Year 2017

 
$

 
6.5

 
$
508

 

 
$

 
6.5

 
$
508

Employee Stock Option [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the fiscal year ended March 31, 2017: 
 
 
Options
(in thousands)
 
Weighted-
Average
Exercise Prices
 
Weighted-
Average
Remaining
Contractual
Term  (in years)
 
Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2016
 
3,278

 
$
35.09

 
 
 
 
Granted
 
6

 
74.93

 
 
 
 
Exercised
 
(876
)
 
40.04

 
 
 
 
Forfeited, cancelled or expired
 
(31
)
 
35.75

 
 
 
 
Outstanding as of March 31, 2017
 
2,377

 
$
33.35

 
5.30
 
$
134

Vested and expected to vest
 
2,358

 
$
33.38

 
5.29
 
$
132

Exercisable as of March 31, 2017
 
1,903

 
$
33.61

 
4.88
 
$
106

Restricted Stock Rights [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
Each restricted stock unit granted reduces the number of shares available for grant by 1.43 shares under our Equity Plan. The following table summarizes our restricted stock units activity, excluding market-based restricted stock unit activity which is discussed below, for the fiscal year ended March 31, 2017: 
 
 
Restricted
Stock Units
(in thousands)
 
Weighted-
Average Grant
Date Fair Values
Balance as of March 31, 2016
 
7,157

 
$
44.04

Granted
 
2,734

 
76.60

Vested
 
(4,126
)
 
37.28

Forfeited or cancelled
 
(612
)
 
58.34

Balance as of March 31, 2017
 
5,153

 
$
65.03


Market Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our market-based restricted stock unit activity for the year ended March 31, 2017: 
 
 
Market-Based
Restricted  Stock
Units
(in thousands)
 
Weighted-
Average  Grant
Date Fair Value
Balance as of March 31, 2016
 
636

 
$
64.49

Granted
 
353

 
98.04

Vested
 
(558
)
 
50.08

Vested above target
 
238

 
44.99

Forfeited or cancelled
 
(28
)
 
84.94

Balance as of March 31, 2017
 
641

 
$
87.37